Inhibition of Hsp70-Bag3, FoxM1 suppression, upregulation of p21 and p27, sensitization of breast cancer to bortezomib in vivo, inhibition of TAM infiltration, sensitization of lung cancer to manumycin A [31,44,45,46,47]. This evidence concerns the gene HSPA1A and breast cancer.